or Try an Advanced Search...

    Technical Analysis for HRMY - Harmony Biosciences Holdings, Inc.

    Grade Last Price % Change Price Change
    D 33.22 0.65% 0.22
    HRMY closed up 0.65 percent on Friday, November 15, 2024, on 71 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
    6 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical HRMY trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.65%
    200 DMA Support Bullish 0.65%
    Down 3 Days in a Row Weakness 0.65%
    Down 4 Days in a Row Weakness 0.65%
    Fell Below 20 DMA Bearish -1.85%
    Down 3 Days in a Row Weakness -1.85%
    50 DMA Resistance Bearish -5.32%
    20 DMA Support Bullish -5.32%
    50 DMA Resistance Bearish -7.50%
    Older End-of-Day Signals for HRMY ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 5 hours ago
    60 Minute Opening Range Breakout about 5 hours ago
    Fell Below 200 DMA about 8 hours ago
    200 DMA Support about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    HRMY Chart by TradingView
    Basic chart:

    Profile

    Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Neurological Disorders Stage Pharmaceutical Ethers Urological Disorders Chloroarenes Narcolepsy Piperidines Rare Neurological Disorders Stimulants

    Is HRMY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points
    Nov 5 There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings
    Nov 1 Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
    Oct 31 Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations
    Oct 31 Harmony Biosciences prices secondary offering at $31 per share
    Oct 31 Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
    Oct 30 Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
    Oct 30 Q3 2024 Harmony Biosciences Holdings Inc Earnings Call
    Oct 29 Harmony Biosciences Holdings announces public offering
    Oct 29 Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
    See more HRMY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 41.61
    52 Week Low 27.105
    Average Volume 843,296
    200-Day Moving Average 32.93
    50-Day Moving Average 35.98
    20-Day Moving Average 34.57
    10-Day Moving Average 34.28
    Average True Range 1.69
    RSI (14) 44.13
    ADX 15.0
    +DI 24.33
    -DI 27.06
    Chandelier Exit (Long, 3 ATRs) 36.55
    Chandelier Exit (Short, 3 ATRs) 36.08
    Upper Bollinger Bands 38.36
    Lower Bollinger Band 30.78
    Percent B (%b) 0.32
    BandWidth 21.93
    MACD Line -0.47
    MACD Signal Line -0.39
    MACD Histogram -0.0737
    Fundamentals Value
    Market Cap 1.95 Billion
    Num Shares 58.6 Million
    EPS 2.47
    Price-to-Earnings (P/E) Ratio 13.45
    Price-to-Sales 3.82
    Price-to-Book 4.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 34.66
    Resistance 3 (R3) 34.59 34.05 34.42
    Resistance 2 (R2) 34.05 33.68 34.08 34.33
    Resistance 1 (R1) 33.63 33.46 33.84 33.70 34.25
    Pivot Point 33.09 33.09 33.20 33.12 33.09
    Support 1 (S1) 32.67 32.72 32.88 32.74 32.18
    Support 2 (S2) 32.13 32.50 32.16 32.10
    Support 3 (S3) 31.71 32.13 32.02
    Support 4 (S4) 31.78